A novel skin brightening topical technology

Area of Science:

• Dermatology
• Cosmetic Science
• Photobiology

Background:

• Effective skin lightening solutions are needed for over-the-counter (OTC) products.
• Current OTC formulations often lack sufficient efficacy for significant skin benefits.

Purpose of the Study:

• To evaluate a novel topical facial formulation containing hexylresorcinol, silymarin, vitamin C, and vitamin E.
• To assess the formulation's photoprotective effects on UVB-exposed skin explants.
• To determine the clinical efficacy of the formulation for skin brightening and overall appearance.

Main Methods:

• In vitro study using 12 skin explants to compare the test product against its vehicle.
• UVB exposure (250 mJ/cm²) applied to half of the explants after 96 hours.
• Clinical trial with 42 female subjects (ages 35-55, skin types I-VI) assessing improvements in brightening, evenness, fine lines, and global appearance over 12 weeks.

Main Results:

• In vitro: The formulation prevented significant changes in pro-collagen and pro-inflammatory gene markers after UVB exposure.
• In vitro: The vehicle alone showed decreased pro-collagen and increased pro-inflammatory markers.
• Clinical: Significant improvements observed by week 12, including 45% in brightening, 27% in evenness, and 25% in fine lines and global appearance (P < .001).

Conclusions:

• The formulation containing hexylresorcinol, silymarin, vitamin C, and vitamin E effectively mitigates UVB-induced photodamage in skin.
• The formulation demonstrates significant clinical benefits, notably improving skin brightness and overall facial appearance.
• This research supports the use of this formulation for enhancing skin photoprotection and achieving visible skin lightening.